CHRISTINA HATCHER: Open Payments
NPI 1184387524 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 62 payments from 22 companies in 2025. Trend: 2023 $3,257 · 2024 $3,875 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $242 |
| Eisai Inc. | 8 | $167 |
| Biogen, Inc. | 4 | $102 |
| UCB, Inc. | 3 | $66 |
| ACADIA Pharmaceuticals Inc | 3 | $63 |
| Neurelis, Inc. | 2 | $56 |
| EMD Serono, Inc. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Grifols USA, LLC | 1 | $39 |
| PFIZER INC. | 2 | $38 |
Products named: Leqembi, UBRELVY, VUMERITY, BOTOX, NUPLAZID, VALTOCO, PONVORY, QULIPTA.
Industry payments across MO — which companies pay providers there.
